Company intelligence / Profile preview
Miist Therapeutics
Alameda, California, United Statesmiisttherapeutics.com ↗
- Ownership
- Private
- Employees
- ~3
- Development stage
- Phase 1
01
Overview
Phase I trial showed that smokers who used Miist's inhaler eliminated 92% of their cravings in only two minutes, which is a 10X improvement over existing standard of care[6]. The company is preparing for Phase II trials for its smoking cessation technology[6].
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Inhaled therapies
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Miist Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Miist Therapeutics.